Oh-Biologica-2023-26 - Insulin Lispro (Atc: A10Ab04, Potency: 100 U/Ml)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 71588563

  Document Type - Tender Notices

Description - The health insurance companies involved pursue the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with Section 130a Paragraph 8 SGB V for the active ingredient insulin lispro (ATC: A10AB04, potency: 10 0 U/ml). The contract is concluded as part of the open house biologics procedure of the participating health insurance companies: Individual negotiations about contract contents are not conducted; uniform conditions apply. The health insurance companies involved do not guarantee individual contractual partners any exclusivity. The contract term is a maximum of 24 months starting on November 1st, 2023. The contract ends on October 31, 2025 at the

Gt Ref Id - 71588563

Deadline - Oct 31, 2025